Evidence map›Paper›PMID 42578489›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2026

Tailoring Symmetry Breaking in Engineered van der Waals Superlattices.

Keda Jin, Lennart Klebl, Zachary A H Goodwin, Junting Zhao, Felix Lüpke, Dante M Kennes, Jose Martinez-Castro, Markus Ternes

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Keda JinPeter Grünberg Institut (PGI-3), Forschungszentrum Jülich, Jülich, Germany.
Lennart KleblInstitut für Theoretische Physik und Astrophysik and Würzburg-Dresden Cluster of Excellence ct.qmat, Universität Würzburg, Würzburg, Germany.ORCID https://orcid.org/0000-0002-5453-9779
Zachary A H GoodwinDepartment of Materials, University of Oxford, Oxford, United Kingdom.
Junting ZhaoPeter Grünberg Institut (PGI-3), Forschungszentrum Jülich, Jülich, Germany.ORCID https://orcid.org/0000-0001-7248-7872
Felix LüpkePeter Grünberg Institut (PGI-3), Forschungszentrum Jülich, Jülich, Germany.
Dante M KennesInstitut für Theorie der statistischen Physik, RWTH Aachen Universität, Aachen, Germany.
Jose Martinez-CastroPeter Grünberg Institut (PGI-3), Forschungszentrum Jülich, Jülich, Germany.
Markus TernesPeter Grünberg Institut (PGI-3), Forschungszentrum Jülich, Jülich, Germany.

Funding

Alexander von Humboldt-StiftungDeutsche Forschungsgemeinschaft 390858490Deutsche Forschungsgemeinschaft 422707584Deutsche Forschungsgemeinschaft 443274199Deutsche Forschungsgemeinschaft 443416235Deutsche Forschungsgemeinschaft 449119662Deutsche Forschungsgemeinschaft 449872909Deutsche Forschungsgemeinschaft 511561801Deutsche Forschungsgemeinschaft INST 222/1296-1 FUGGDeutsche Forschungsgemeinschaft TE 833/2Glasstone Research Fellowship
6 · The paper itself

Abstract

Superlattice engineering in van der Waals (vdW) heterostructures (e.g., by moiré engineering) provides a powerful platform for designing electronic bands and realizing correlated and topological quantum phenomena. Here, we pioneer a scheme to tailor superpotentials based on intrinsic substrate electronic orders. We show that this establishes a robust, self-aligned, and highly versatile route to band-structure control, as we demonstrate in graphene by engineering two distinct, nearly commensurate superlattices using the charge density waves (CDWs) of 1T-NbSe

Indexed as

charge density wavesscanning tunneling microscopysuperlattice engineeringsymmetry breakingvan der Waals heterostructures

Identifiers

PMID42578489
PMCPMC13660823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.